Page 59 - Read Online

Page 10 of 10 Chien et al. J Cancer Metastasis Treat 2019;5:66 I http://dx.doi.org/10.20517/2394-4722.2019.016

Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial. JAMA 2015;314:2535-43.
69. Kessler AF, Frömbling GE, Gross F, Hahn M, Dzokou W, et al. Effects of tumor treating fields (TTFields) on glioblastoma cells are
augmented by mitotic checkpoint inhibition. Cell Death Discov 2018;4:12.
70. Shteingauz A, Porat Y, Voloshin T, Schneiderman RS, Munster M, et al. AMPK-dependent autophagy upregulation serves as a survival
mechanism in response to Tumor Treating Fields (TTFields). Cell Death Dis 2018;9:1074.
71. Ullén A, Farnebo M, Thyrell L, Mahmoudi S, Kharaziha P, et al. Sorafenib induces apoptosis and autophagy in prostate cancer cells in vitro.
Int J Oncol 2010;37:15-20.
72. Jo Y, Kim EH, Sai S, Kim JS, Cho JM, et al. Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for
Glioblastoma Therapy. Int J Mol Sci 2018;19:E3684.
73. Karanam NK, Srinivasan K, Ding L, Sishc B, Saha D, et al. Tumor-treating fields elicit a conditional vulnerability to ionizing radiation via
the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell lines. Cell
Death Dis 2017;8:e2711.
74. Giladi M, Munster M, Schneiderman RS, Voloshin T, Porat Y, et al. Tumor treating fields (TTFields) delay DNA damage repair following
radiation treatment of glioma cells. Radiat Oncol 2017;12:206.
75. Narasimha K, Liang-hao D, Brock S, Debabrata S, Michael S. CSIG-01, Tumor Treatment Fields downregulate specific transcription factors
leading to reduced DNA repair capacity, increased replication stress, the inhibition of mitophagy and enhanced cell death. Neuro Oncol
2017;19:vi49-50.
76. Huang H, Song J, Liu Z, Pan L, Xu G. Autophagy activation promotes bevacizumab resistance in glioblastoma by suppressing Akt/mTOR
signaling pathway. Oncol Lett 2018;15:1487-94.
77. Keunen O, Johansson M, Oudin A, Sanzey M, Rahim SA, et al. Anti-VEGF treatment reduces blood supply and increases tumor cell
invasion in glioblastoma. Proc Natl Acad Sci U S A 2011;108:3749-54.
78. Abdul Rahim SA, Dirkse A, Oudin A, Schuster A, Bohler J, et al. Regulation of hypoxia-induced autophagy in glioblastoma involves
ATG9A. Br J Cancer 2017;117:813-25.
79. Miranda-Gonçalves V, Cardoso-Carneiro D, Valbom I, Cury FP, Silva VA, et al. Metabolic alterations underlying Bevacizumab therapy in
glioblastoma cells. Oncotarget 2017;8:103657-70.
80. Wu HB, Yang S, Weng HY, Chen Q, Zhao XL, et al. Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic
mimicry by glioma stem cells. Autophagy 2017;13:1528-42.
81. Biasoli D, Kahn SA, Cornélio TA, Furtado M, Campanati L, et al. Retinoblastoma protein regulates the crosstalk between autophagy and
apoptosis, and favors glioblastoma resistance to etoposide. Cell Death Dis 2013;4:e767.
82. Wang Z, Liang P, He X, Wu B, Liu Q, et al. Etoposide loaded layered double hydroxide nanoparticles reversing chemoresistance and
eradicating human glioma stem cells in vitro and in vivo. Nanoscale 2018;10:13106-21.
83. Sheleg SV, Korotkevich EA, Zhavrid EA, Muravskaya GV, Smeyanovich AF, et al. Local chemotherapy with cisplatin-depot for
glioblastoma multiforme. J Neurooncol 2002;60:53-9.
84. Ren JH, He WS, Nong L, Zhu QY, Hu K, et al. Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with
enhanced autophagy. Cancer Biother Radiopharm 2010;25:75-80.
85. Bao LJ, Jaramillo MC, Zhang ZB, Zheng YX, Yao M, et al. Nrf2 induces cisplatin resistance through activation of autophagy in ovarian
carcinoma. Int J Clin Exp Pathol 2014;7:1502-13.
86. Yu L, Gu C, Zhong D, Shi L, Kong Y, et al. Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal
cancer cells with acquired drug resistance. Cancer Lett 2014;355:34-45.
87. Liu X, Sun K, Wang H, Dai Y. Knockdown of retinoblastoma protein may sensitize glioma cells to cisplatin through inhibition of autophagy.
Neurosci Lett 2016;620:137-42.
88. Xu Y, Yu H, Qin H, Kang J, Yu C, et al. Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in
human cervical cancer cells. Cancer Lett 2012;314:232-43.
89. Ma B, Gao Z, Lou J, Zhang H, Yuan Z, et al. Long noncoding RNA MEG3 contributes to cisplatininduced apoptosis via inhibition of
autophagy in human glioma cells. Mol Med Rep 2017;16:2946-52.
90. Ding L, Yuan C, Wei F, Wang G, Zhang J, et al. Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-
regulation of DR5 and down-regulation of c-FLIP. Cancer Invest 2011;29:511-20.
91. Lv S, Wang X, Zhang N, Sun M, Qi W, et al. Autophagy facilitates the development of resistance to the tumor necrosis factor superfamily
member TRAIL in breast cancer. Int J Oncol 2015;46:1286-94.
92. Potapova O, Haghighi A, Bost F, Liu C, Birrer MJ, et al. The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA
repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J Biol Chem 1997;272:14041-4.
93. Kuo CC, Liu TW, Chen LT, Shiah HS, Wu CM, et al. Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated
autophagic cell death in human solid tumors. Free Radic Biol Med 2011;51:2195-209.
94. Sukumari-Ramesh S, Prasad N, Alleyne CH, Vender JR, Dhandapani KM. Overexpression of Nrf2 attenuates Carmustine-induced
cytotoxicity in U87MG human glioma cells. BMC Cancer 2015;15:118.
95. Yayon A, Cabantchik ZI, Ginsburg H. Susceptibility of human malaria parasites to chloroquine is pH dependent. Proc Natl Acad Sci U S A
1985;82:2784-8.
96. Geng Y, Kohli L, Klocke BJ, Roth KA. Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53
independent. Neuro Oncol 2010;12:473-81.
97. Briceno E, Reyes S, Sotelo J. Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine. Neurosurg Focus 2003;14:e3